Table 4 Univariable and multivariable analyses for each clinical feature
Clinical feature | Number | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|---|
HR | 95%CI of HR | P value | HR | 95%CI of HR | P value | ||
Risk parameter (High-risk/Low-risk) | 274/274 | 3.529 | 2.186–5.699 | < 0.001 | 2.482 | 1.832–4.258 | 0.038 |
Age (≥ 66/< 66) | 236/310 | 1.817 | 1.180–2.798 | 0.007 | 1.482 | 0.820–2.678 | 0.192 |
Stage (I/II–IV) | 341/207 | 3.577 | 2.288–5.594 | < 0.001 | 1.658 | 1.010–2.721 | 0.046 |
Grade (G1/G2–3) | 99/438 | 12.811 | 3.148–52.128 | < 0.001 | 7.826 | 1.052–58.205 | 0.044 |
Residual tumor (yes/no) | 22/376 | 2.884 | 1.778–4.678 | < 0.001 | 0.745 | 0.402–1.380 | 0.349 |
New tumor event (yes/no) | 63/485 | 4.931 | 3.189–7.625 | < 0.001 | 2.773 | 1.604–4.798 | < 0.001 |
Neoplasm cancer status (with tumor/tumor free) | 79/431 | 6.404 | 4.140–9.908 | < 0.001 | 3.509 | 1.895–6.498 | < 0.001 |
Histological type (endometrioid adenocarcinoma/others) | 411/137 | 1.854 | 1.186–2.896 | 0.007 | 0.708 | 0.406–1.237 | 0.225 |